Guided Therapeutics (GTHP) Current Assets (2010 - 2025)

Guided Therapeutics has disclosed Current Assets across 16 years of filings, most recently posting $605000.0 for Q4 2025.

• Current Assets for Q4 2025 came in at $605000.0, down 49.46% year-over-year; the trailing twelve-month figure through Dec 2025 was $605000.0 (down 49.46% YoY), and the FY2025 annual result was $605000.0, down 49.46% from the prior year.
• Current Assets came in at $605000.0 for Q4 2025 at Guided Therapeutics, down from $799000.0 in the prior quarter.
• In the past five years, Current Assets ranged from a high of $3.5 million in Q3 2022 to a low of $605000.0 in Q4 2025.
• The 5-year median for Current Assets is $1.4 million (2021), against an average of $1.5 million.
• Across the five-year window, Current Assets soared 705.04% in 2021 and plunged 54.8% in 2023, its largest moves.
• Guided Therapeutics' Current Assets stood at $1.6 million in 2021, then jumped by 83.51% to $3.0 million in 2022, then sank by 53.63% to $1.4 million in 2023, then dropped by 14.07% to $1.2 million in 2024, then tumbled by 49.46% to $605000.0 in 2025.
• The last three Current Assets figures came in at $605000.0 (Q4 2025), $799000.0 (Q3 2025), and $811000.0 (Q2 2025), per Business Quant data.